NYU School of Medicine, Neurogenetics Division

160 East 34th Street
New York, New York 10016

We've found

1 trials

at this facility

Ascending Dose Study of Genome Editing by the Zinc Finger Nuclease (ZFN) Therapeutic SB-913 in Subjects With MPS II

Status: Enrolling, Phase I
Updated: 12/31/1969

from

New York, NY

Use our guide to learn which trials are right for you!